Search Results - "Veluvolu, Sridhar M."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Clinical outcomes, ultrastructure and immunohistochemical features of canine high‐grade olfactory neuroblastoma by Church, Molly E., Veluvolu, Sridhar M., Durham, Amy C., Woolard, Kevin D.

    Published in Veterinary & comparative oncology (01-12-2019)
    “…Olfactory neuroblastoma (ONB) is a rare intranasal neoplasm in both dogs and humans. Similar clinical presentation and overlapping histologic and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Importance of pharmacologic considerations in the development of targeted anticancer agents for children by Veluvolu, Sridhar M., Grohar, Patrick J.

    Published in Current opinion in pediatrics (01-02-2023)
    “…The purpose of this review is to describe key pharmacologic considerations to inform strategies in drug development for pediatric cancer. Main themes that will…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Canine leishmaniasis in Northern California—A case report by Alonso, Flavio H., Vasilatis, Demitria M., Veluvolu, Sridhar M., Willcox, Jennifer L., Scorza, Breanna M., Petersen, Christine A., Kol, Amir

    Published in Veterinary clinical pathology (01-03-2021)
    “…A 3‐year‐old dog was referred to the Veterinary Medical Teaching Hospital of the University of California‐Davis for further evaluation of episodes of epistaxis…”
    Get full text
    Journal Article
  6. 6

    Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats by MaloneyHuss, Martha A, Mauldin, Glenna E, Brown, Dorothy C, Veluvolu, Sridhar M, Krick, Erika L

    Published in Journal of feline medicine and surgery (01-04-2020)
    “…Objectives The aims of this study were to evaluate the safety of mustargen, vincristine, procarbazine and prednisone (MOPP) chemotherapy in the treatment of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Abstract 1082: Exploiting lurbinectedin-driven nucleolar relocalization of EWS-FLI1 to develop novel combination therapies for Ewing sarcoma by Veluvolu, Sridhar M., Lopez, Raphael D., Gedminas, Jenna M., Boguslawski, Elissa A., Wilson, Elizabeth R., Caiello, Benjamin P., Murphy, Maureen E., Grohar, Patrick J.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Background: Ewing sarcoma (ES) is a malignant bone tumor characterized by the oncogenic fusion protein EWS-FLI1. EWS-FLI1 acts as an aberrant transcription…”
    Get full text
    Journal Article
  9. 9

    Cover Image, Volume 17, Issue 4 by Church, Molly E., Veluvolu, Sridhar M., Durham, Amy C., Woolard, Kevin D.

    Published in Veterinary & comparative oncology (01-12-2019)
    “…The cover image is based on the SHORT COMMUNICATION Clinical outcomes, ultrastructure and immunohistochemical features of canine high‐grade olfactory…”
    Get full text
    Journal Article
  10. 10